153 related articles for article (PubMed ID: 11256837)
1. Intravenous 5-fluorouracil versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer: prospective randomized trials.
Kim NK; Min JS; Park JK; Yun SH; Sung JS; Jung HC; Roh JK
Jpn J Clin Oncol; 2001 Jan; 31(1):25-9. PubMed ID: 11256837
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial comparing intravenous 5-fluorouracil and oral doxifluridine as postoperative adjuvant treatment for advanced rectal cancer.
Min JS; Kim NK; Park JK; Yun SH; Noh JK
Ann Surg Oncol; 2000 Oct; 7(9):674-9. PubMed ID: 11034245
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer.
Seong J; Cho JH; Kim NK; Min JS; Suh CO
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):435-9. PubMed ID: 11380231
[TBL] [Abstract][Full Text] [Related]
5. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer.
Hsieh CH; Chen YJ; Chang KH; Hsu HH; Liu CK; Hung SK; Chen HW; Lai YL; Hsu TC
Anticancer Res; 2006; 26(5B):3709-15. PubMed ID: 17094389
[TBL] [Abstract][Full Text] [Related]
6. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.
Janjan NA; Crane C; Feig BW; Cleary K; Dubrow R; Curley S; Vauthey JN; Lynch P; Ellis LM; Wolff R; Lenzi R; Abbruzzese J; Pazdur R; Hoff PM; Allen P; Brown T; Skibber J
Am J Clin Oncol; 2001 Apr; 24(2):107-12. PubMed ID: 11319280
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
8. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation.
Chen ET; Mohiuddin M; Brodovsky H; Fishbein G; Marks G
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):169-75. PubMed ID: 8083110
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer.
Kim JS; Kim JS; Cho MJ; Yoon WH; Song KS
J Korean Med Sci; 2006 Feb; 21(1):52-7. PubMed ID: 16479065
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation.
Valentini V; Coco C; Cellini N; Picciocchi A; Rosetto ME; Mantini G; Marmiroli L; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1175-84. PubMed ID: 10613310
[TBL] [Abstract][Full Text] [Related]
11. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled pilot study to compare capecitabine-oxaliplatin with 5-FU-leucovorin as neoadjuvant concurrent chemoradiation in locally advanced adenocarcinoma of rectum.
Saha A; Ghosh SK; Roy C; Saha ML; Choudhury KB; Chatterjee K
J Cancer Res Ther; 2015; 11(1):88-93. PubMed ID: 25879343
[TBL] [Abstract][Full Text] [Related]
13. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.
Janjan NA; Crane CN; Feig BW; Cleary K; Dubrow R; Curley SA; Ellis LM; Vauthey J; Lenzi R; Lynch P; Wolff R; Brown T; Pazdur R; Abbruzzese J; Hoff PM; Allen P; Brown B; Skibber J
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):713-8. PubMed ID: 10837955
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
Arkenau HT; Rettig K; Porschen R
Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
[TBL] [Abstract][Full Text] [Related]
15. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.
Videtic GM; Fisher BJ; Perera FE; Bauman GS; Kocha WI; Taylor M; Vincent MD; Plewes EA; Engel CJ; Stitt LW
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):319-24. PubMed ID: 9788410
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.
Cambray i Amenós M; Navarro García M; Martí Ragué J; Pareja Fernández L; Pera Fábregas J
Clin Transl Oncol; 2007 Mar; 9(3):183-91. PubMed ID: 17403630
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
[TBL] [Abstract][Full Text] [Related]
19. Integrated treatment with doxifluridine and radiotherapy in recurrent or primary unresectable rectal cancer. A feasibility study.
Di Bartolomeo M; Bajetta E; Buzzoni R; Bozzetti F; Artale S; Valvo F
Tumori; 1999; 85(3):211-3. PubMed ID: 10426135
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
Movsas B; Diratzouian H; Hanlon A; Cooper H; Freedman G; Konski A; Sigurdson E; Hoffman J; Meropol NJ; Weiner LM; Coia L; Lanciano R; Stein J; Kister D; Eisenberg B
Am J Clin Oncol; 2006 Oct; 29(5):435-41. PubMed ID: 17023775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
